Neupogen & Off label use

25.5%

of users reported Off label use

65.1%

also reported Severe reaction

67.7%

are women

Severe reaction

65.1%

Hospitalization

19.0%

Death

14.3%

Life-threatening condition

1.6%

Neupogen: general information

0 - 9 years

3.5%

10 - 19 years

0.7%

20 - 29 years

3.6%

30 - 39 years

8.9%

40 - 49 years

15.3%

50 - 59 years

21.2%

60 - 69 years

29.6%

70 - 79 years

15.4%

80 - 89 years

1.8%